A Universal Influenza Virus Vaccine Candidate Tested in a Pig Vaccination-Infection Model in the Presence of Maternal Antibodies.
- Published in:
- Vaccines, 2018, v. 6, n. 3, p. 64, doi. 10.3390/vaccines6030064
- By:
- Publication type:
- Article
Works matching IS 2076393X AND DT 2018 AND VI 6 AND IP 3
Results: 31
1
2
Cathelicidins: Immunomodulatory Antimicrobials.
- Published in:
- Vaccines, 2018, v. 6, n. 3, p. 63, doi. 10.3390/vaccines6030063
- By:
- Publication type:
- Article
3
Zika Virus Vaccines: Challenges and Perspectives.
- Published in:
- Vaccines, 2018, v. 6, n. 3, p. 62, doi. 10.3390/vaccines6030062
- By:
- Publication type:
- Article
4
Prevention of Cervical Cancer in Sub-Saharan Africa: The Advantages and Challenges of HPV Vaccination.
- Published in:
- Vaccines, 2018, v. 6, n. 3, p. 61, doi. 10.3390/vaccines6030061
- By:
- Publication type:
- Article
5
Novel Whole-Cell Inactivated Neisseria Gonorrhoeae Microparticles as Vaccine Formulation in Microneedle-Based Transdermal Immunization.
- Published in:
- Vaccines, 2018, v. 6, n. 3, p. 60, doi. 10.3390/vaccines6030060
- By:
- Publication type:
- Article
6
BDCA1+CD14+ Immunosuppressive Cells in Cancer, a Potential Target?.
- Published in:
- Vaccines, 2018, v. 6, n. 3, p. 65, doi. 10.3390/vaccines6030065
- By:
- Publication type:
- Article
7
Relative Clinical and Cost Burden of Community-Acquired Pneumonia Hospitalizations in Older Adults in the United States—A Cross-Sectional Analysis.
- Published in:
- Vaccines, 2018, v. 6, n. 3, p. 59, doi. 10.3390/vaccines6030059
- By:
- Publication type:
- Article
8
The Future of Influenza Vaccines: A Historical and Clinical Perspective.
- Published in:
- Vaccines, 2018, v. 6, n. 3, p. 58, doi. 10.3390/vaccines6030058
- By:
- Publication type:
- Article
9
β-Defensins Coordinate In Vivo to Inhibit Bacterial Infections of the Trachea.
- Published in:
- Vaccines, 2018, v. 6, n. 3, p. 57, doi. 10.3390/vaccines6030057
- By:
- Publication type:
- Article
10
Endometrial Stromal Sarcomas: A Revision of Their Potential as Targets for Immunotherapy.
- Published in:
- Vaccines, 2018, v. 6, n. 3, p. 56, doi. 10.3390/vaccines6030056
- By:
- Publication type:
- Article
11
Therapeutic Vaccines for Genitourinary Malignancies.
- Published in:
- Vaccines, 2018, v. 6, n. 3, p. 55, doi. 10.3390/vaccines6030055
- By:
- Publication type:
- Article
12
Early Investigations and Recent Advances in Intraperitoneal Immunotherapy for Peritoneal Metastasis.
- Published in:
- Vaccines, 2018, v. 6, n. 3, p. 54, doi. 10.3390/vaccines6030054
- By:
- Publication type:
- Article
13
The Vestigial Esterase Domain of Haemagglutinin of H5N1 Avian Influenza A Virus: Antigenicity and Contribution to Viral Pathogenesis.
- Published in:
- Vaccines, 2018, v. 6, n. 3, p. 53, doi. 10.3390/vaccines6030053
- By:
- Publication type:
- Article
14
Next Generation Cancer Vaccines—Make It Personal!.
- Published in:
- Vaccines, 2018, v. 6, n. 3, p. 52, doi. 10.3390/vaccines6030052
- By:
- Publication type:
- Article
15
Cytokines IL-17, TNF and IFN-γ Alter the Expression of Antimicrobial Peptides and Proteins Disparately: A Targeted Proteomics Analysis using SOMAscan Technology.
- Published in:
- Vaccines, 2018, v. 6, n. 3, p. 51, doi. 10.3390/vaccines6030051
- By:
- Publication type:
- Article
16
Activation-induced Markers Detect Vaccine-Specific CD4+ T Cell Responses Not Measured by Assays Conventionally Used in Clinical Trials.
- Published in:
- Vaccines, 2018, v. 6, n. 3, p. 50, doi. 10.3390/vaccines6030050
- By:
- Publication type:
- Article
17
Contribution of Host Defence Proteins and Peptides to Host-Microbiota Interactions in Chronic Inflammatory Lung Diseases.
- Published in:
- Vaccines, 2018, v. 6, n. 3, p. 49, doi. 10.3390/vaccines6030049
- By:
- Publication type:
- Article
18
Listeria monocytogenes as a Vector for Cancer Immunotherapy: Current Understanding and Progress.
- Published in:
- Vaccines, 2018, v. 6, n. 3, p. 48, doi. 10.3390/vaccines6030048
- By:
- Publication type:
- Article
19
A Live-Attenuated Prime, Inactivated Boost Vaccination Strategy with Chimeric Hemagglutinin-Based Universal Influenza Virus Vaccines Provides Protection in Ferrets: A Confirmatory Study.
- Published in:
- Vaccines, 2018, v. 6, n. 3, p. 47, doi. 10.3390/vaccines6030047
- By:
- Publication type:
- Article
20
Avian Influenza A Virus Pandemic Preparedness and Vaccine Development.
- Published in:
- Vaccines, 2018, v. 6, n. 3, p. 46, doi. 10.3390/vaccines6030046
- By:
- Publication type:
- Article
21
Why Is Eradicating Typhoid Fever So Challenging: Implications for Vaccine and Therapeutic Design.
- Published in:
- Vaccines, 2018, v. 6, n. 3, p. 45, doi. 10.3390/vaccines6030045
- By:
- Publication type:
- Article
22
Effects of LL-37 on Gingival Fibroblasts: A Role in Periodontal Tissue Remodeling?.
- Published in:
- Vaccines, 2018, v. 6, n. 3, p. 44, doi. 10.3390/vaccines6030044
- By:
- Publication type:
- Article
23
Methods for Measuring T-Cell Memory to Vaccination: From Mouse to Man.
- Published in:
- Vaccines, 2018, v. 6, n. 3, p. 43, doi. 10.3390/vaccines6030043
- By:
- Publication type:
- Article
24
Improved Induction of Anti-Melanoma T Cells by Adenovirus-5/3 Fiber Modification to Target Human DCs.
- Published in:
- Vaccines, 2018, v. 6, n. 3, p. 42, doi. 10.3390/vaccines6030042
- By:
- Publication type:
- Article
25
Respiratory Tract Deposition and Distribution Pattern of Microparticles in Mice Using Different Pulmonary Delivery Techniques.
- Published in:
- Vaccines, 2018, v. 6, n. 3, p. 41, doi. 10.3390/vaccines6030041
- By:
- Publication type:
- Article
26
Protective Cancer Vaccine Using Genetically Modified Hematopoietic Stem Cells.
- Published in:
- Vaccines, 2018, v. 6, n. 3, p. 40, doi. 10.3390/vaccines6030040
- By:
- Publication type:
- Article
27
The Effects of Birth Year, Age and Sex on Hemagglutination Inhibition Antibody Responses to Influenza Vaccination.
- Published in:
- Vaccines, 2018, v. 6, n. 3, p. 39, doi. 10.3390/vaccines6030039
- By:
- Publication type:
- Article
28
The Immunity Gap Challenge: Protection against a Recent Florida Clade 2 Equine Influenza Strain.
- Published in:
- Vaccines, 2018, v. 6, n. 3, p. 38, doi. 10.3390/vaccines6030038
- By:
- Publication type:
- Article
29
Interaction of Viral Capsid-Derived Virus-Like Particles (VLPs) with the Innate Immune System.
- Published in:
- Vaccines, 2018, v. 6, n. 3, p. 37, doi. 10.3390/vaccines6030037
- By:
- Publication type:
- Article
30
The Role of Fc Gamma Receptors in Broad Protection against Influenza Viruses.
- Published in:
- Vaccines, 2018, v. 6, n. 3, p. 36, doi. 10.3390/vaccines6030036
- By:
- Publication type:
- Article
31
Neutralizing Anti-Hemagglutinin Monoclonal Antibodies Induced by Gene-Based Transfer Have Prophylactic and Therapeutic Effects on Influenza Virus Infection.
- Published in:
- Vaccines, 2018, v. 6, n. 3, p. 35, doi. 10.3390/vaccines6030035
- By:
- Publication type:
- Article